Forex Day trading With Multiple Timeframe Analysis

AppId is over the quota
AppId is over the quota

It is not uncommon to see people new to the business of trading try to utilise 5 minute charts and experience numerous losses in the process of doing so.  This is not to say that trading higher timeframe charts is a simple path to success  – because it is not. Higher timeframe charts do however remove some of the noise which is exacerbated when trading with the lower timeframe Forex charts.   A 20 pip stop loss can be hit in seconds during major event risk or even on interaction with a technical level.

Does this mean that lower timeframe Forex trading is an exercise in futility?  I would say this is not the case but an awareness of the bigger picture is essential.  This post will look at a top down analysis piece which culminated in a trade on the 5 minute timeframe charts.  As you will see there was a lot of thought going into the setup and it was not limited to the 5 minute chart in isolation

This trade was on the GBPUSD currency pair.  Our weekly GBPUSD analysis brought to light the following information re the pound/dollar major.

Price was trading just above the psychological 1.6000 GBPUSD handle.Commitment of traders COT report data showed the pound was relatively robust in terms of non-commercial (large speculators) positioning.Price was moving into a confluence area of potential support on the higher timeframe charts.

Now you may see this as irrelevant, when looking to trade intra-day on the lower timeframe, but it tells us there is a chance the bigger traders will be looking for GBPUSD longs as the new week begins.  At the very least it shows us that the market is not “overtly” bearish on the pound.

Further to this we have a gap down on EURUSD and the dollar index gaps higher.  The gap was still open as the Frankfurt/London Open session begins  and some traders may be looking to initiate a gap trade play.  This information is noted down before the trading day begins.

So the top down analysis had shown that price did not close below support. If the bears are trapped in a net breakeven or worse trade and do not see further downside they may need to liquidate positions. Even if they have a profit on the table and see price stalling at support they may become nervous and take a profit before the London open.

All of the above is supplementary information compared with the last piece of the puzzle.  As the Frankfurt and London markets open cable tests double bottom area support following a strong 5 minute bearish candle (see price action within the red circle above). 

The next candle (prior to the trigger candle) is hinting that price my be running out of bearish momentum with the small wick below.  This is not really a strong signal on its own though.  The next candle was my trigger to go long.  A 5-minute bullish engulfing candle at the double bottom area.  A 5 minute trade signal like this is not uncommon but the time (liquidity hitting the market at European open) and location (price structure support) made it stand out in my eyes. 

I was already aware that there was not event risk due and had checked the financial calendar schedule.  The spread was checked before trade initiation to make sure it was acceptable.  The exit was at the horizontal dotted black line above.  Traders differ in this area (profit taking) but I prefer to grab a quick profit and minimise risk.

The trade lasted around 10 minutes and went smoothly to the target (it does not always work out so well… trust me).  If price had of hesitated at the down sloping trend line a decision would have need to be made regarding potentially closing out early.  

Hopefully this gives an insight into the preparation that goes into a trade idea.  Do not go out and try to replicate this.  The post is purely for commentary purposes only and not a recommendation on how to trade.  Take care out there.

Related posts:

App Store From FXCMDollar Index Analysis 16th May 2012Dollar Index Technical Analysis 15/5/2012Forex Broker Articles – What is easy-forex?Gold Technical Analysis Update 12th May

View the original article here

Advancements in Stem Cell Research and Multiple Sclerosis Treatments

Multiple sclerosis is a disease of the immune system that affects the central nervous system, or brain and spinal cord. A form of auto-immune disease, the disease damages the nerves and may affect separate or multiple parts of the body, causing pain and severe limitation to movement, ability, and quality of life.

The disease causes damage and destruction to the protective covering (myelin sheath) that surrounds nerve cells. Damage to the myelin sheath severely slows or interrupts nerve impulses, causing intense pain and inability to control movement. Individuals diagnosed with multiple sclerosis experience episodes of inflammation that cause the body's immune cells to attack the nervous system.

Stem Cell Technologies and Multiple Sclerosis
In recent months, treating a patient who has been diagnosed with multiple sclerosis with their own immune system stem-cells has shown promise in some clinical trials where severe nerve cell damage has not yet occurred.

Clinical trials developed at the Northwestern University Feinberg School Of Medicine in Chicago removed patient's stem-cells in bone marrow, injected chemicals to destroy damaged immune cells and then re-injected the stem-cells into the patient's bodies. Three years later, none of the 23 individuals who engaged in the clinical trials experienced further deterioration, while 17 of them showed some improvement.

In further studies, adult stem-cells that have been taken from a patient's fatty tissues have shown promise in reducing clinical manifestation of the disease process. Clinical trials using mesenchymal stem-cells showed improvement, according to the Journal Of Translational Medicine, describing studies performed at the University of California San Diego. Mesenchymal stem-cells have been shown to reduce or stop immune activation of cells and target specific areas where tissue damage had occurred.

Use of stem-cell technologies to treat multiple sclerosis is designed to literally "reset" immune system function and is focusing on reversing or slowing early diagnosis of multiple sclerosis. Recently, an international symposium (Stem Cell Transplantation in Multiple Sclerosis: Sharing The Experience) was conducted in Moscow, Russia to discuss perspectives in new methods of treating multiple sclerosis through autologous hematopoietic (bone marrow stem-cells that may 'morph' or develop into a variety of stem cell types)stem-cell transplantation combined with high dose immunosuppressive therapies.

The Future of Treatment
In recent months, Brainstorm Cell Therapeutics, Inc., has developed a therapeutic approach for potential treatment of multiple muscular conditions including Parkinson's disease, ALS and multiple-sclerosis. Multiple sclerosis treatments are currently being conducted on mouse models, with results published in the Journal Of Molecular Neuroscience.

Benefits of such treatment offer individuals diagnosed with multiple-sclerosis, especially those diagnosed early, with renewed neural and muscular function, reduced symptoms and enhanced quality of life. News articles abound with stories of various stages of recovery of those who have undergone stem-cell treatment for multiple-sclerosis, some who have even recovered the ability to walk.

From Australia to Europe, individuals undergoing clinical trials of stem-cell therapy have been showing a 60 to 80% chance of slowing the disease process, while some may enjoy the benefits of reversing the disease in its entirety. While there is no cure as yet for multiple-sclerosis, stem-cell treatments that focus on repair and regeneration of the central nervous system offer hope to individuals suffering from neural damage around the globe.

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Advancements in Stem Cell Research and Multiple Sclerosis Treatments

Multiple sclerosis is a disease of the immune system that affects the central nervous system, or brain and spinal cord. A form of auto-immune disease, the disease damages the nerves and may affect separate or multiple parts of the body, causing pain and severe limitation to movement, ability, and quality of life.

The disease causes damage and destruction to the protective covering (myelin sheath) that surrounds nerve cells. Damage to the myelin sheath severely slows or interrupts nerve impulses, causing intense pain and inability to control movement. Individuals diagnosed with multiple sclerosis experience episodes of inflammation that cause the body's immune cells to attack the nervous system.

Stem Cell Technologies and Multiple Sclerosis
In recent months, treating a patient who has been diagnosed with multiple sclerosis with their own immune system stem-cells has shown promise in some clinical trials where severe nerve cell damage has not yet occurred.

Clinical trials developed at the Northwestern University Feinberg School Of Medicine in Chicago removed patient's stem-cells in bone marrow, injected chemicals to destroy damaged immune cells and then re-injected the stem-cells into the patient's bodies. Three years later, none of the 23 individuals who engaged in the clinical trials experienced further deterioration, while 17 of them showed some improvement.

In further studies, adult stem-cells that have been taken from a patient's fatty tissues have shown promise in reducing clinical manifestation of the disease process. Clinical trials using mesenchymal stem-cells showed improvement, according to the Journal Of Translational Medicine, describing studies performed at the University of California San Diego. Mesenchymal stem-cells have been shown to reduce or stop immune activation of cells and target specific areas where tissue damage had occurred.

Use of stem-cell technologies to treat multiple sclerosis is designed to literally "reset" immune system function and is focusing on reversing or slowing early diagnosis of multiple sclerosis. Recently, an international symposium (Stem Cell Transplantation in Multiple Sclerosis: Sharing The Experience) was conducted in Moscow, Russia to discuss perspectives in new methods of treating multiple sclerosis through autologous hematopoietic (bone marrow stem-cells that may 'morph' or develop into a variety of stem cell types)stem-cell transplantation combined with high dose immunosuppressive therapies.

The Future of Treatment
In recent months, Brainstorm Cell Therapeutics, Inc., has developed a therapeutic approach for potential treatment of multiple muscular conditions including Parkinson's disease, ALS and multiple-sclerosis. Multiple sclerosis treatments are currently being conducted on mouse models, with results published in the Journal Of Molecular Neuroscience.

Benefits of such treatment offer individuals diagnosed with multiple-sclerosis, especially those diagnosed early, with renewed neural and muscular function, reduced symptoms and enhanced quality of life. News articles abound with stories of various stages of recovery of those who have undergone stem-cell treatment for multiple-sclerosis, some who have even recovered the ability to walk.

From Australia to Europe, individuals undergoing clinical trials of stem-cell therapy have been showing a 60 to 80% chance of slowing the disease process, while some may enjoy the benefits of reversing the disease in its entirety. While there is no cure as yet for multiple-sclerosis, stem-cell treatments that focus on repair and regeneration of the central nervous system offer hope to individuals suffering from neural damage around the globe.

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Advancements in Stem Cell Research and Multiple Sclerosis Treatments

Multiple sclerosis is a disease of the immune system that affects the central nervous system, or brain and spinal cord. A form of auto-immune disease, the disease damages the nerves and may affect separate or multiple parts of the body, causing pain and severe limitation to movement, ability, and quality of life.

The disease causes damage and destruction to the protective covering (myelin sheath) that surrounds nerve cells. Damage to the myelin sheath severely slows or interrupts nerve impulses, causing intense pain and inability to control movement. Individuals diagnosed with multiple sclerosis experience episodes of inflammation that cause the body's immune cells to attack the nervous system.

Stem Cell Technologies and Multiple Sclerosis
In recent months, treating a patient who has been diagnosed with multiple sclerosis with their own immune system stem-cells has shown promise in some clinical trials where severe nerve cell damage has not yet occurred.

Clinical trials developed at the Northwestern University Feinberg School Of Medicine in Chicago removed patient's stem-cells in bone marrow, injected chemicals to destroy damaged immune cells and then re-injected the stem-cells into the patient's bodies. Three years later, none of the 23 individuals who engaged in the clinical trials experienced further deterioration, while 17 of them showed some improvement.

In further studies, adult stem-cells that have been taken from a patient's fatty tissues have shown promise in reducing clinical manifestation of the disease process. Clinical trials using mesenchymal stem-cells showed improvement, according to the Journal Of Translational Medicine, describing studies performed at the University of California San Diego. Mesenchymal stem-cells have been shown to reduce or stop immune activation of cells and target specific areas where tissue damage had occurred.

Use of stem-cell technologies to treat multiple sclerosis is designed to literally "reset" immune system function and is focusing on reversing or slowing early diagnosis of multiple sclerosis. Recently, an international symposium (Stem Cell Transplantation in Multiple Sclerosis: Sharing The Experience) was conducted in Moscow, Russia to discuss perspectives in new methods of treating multiple sclerosis through autologous hematopoietic (bone marrow stem-cells that may 'morph' or develop into a variety of stem cell types)stem-cell transplantation combined with high dose immunosuppressive therapies.

The Future of Treatment
In recent months, Brainstorm Cell Therapeutics, Inc., has developed a therapeutic approach for potential treatment of multiple muscular conditions including Parkinson's disease, ALS and multiple-sclerosis. Multiple sclerosis treatments are currently being conducted on mouse models, with results published in the Journal Of Molecular Neuroscience.

Benefits of such treatment offer individuals diagnosed with multiple-sclerosis, especially those diagnosed early, with renewed neural and muscular function, reduced symptoms and enhanced quality of life. News articles abound with stories of various stages of recovery of those who have undergone stem-cell treatment for multiple-sclerosis, some who have even recovered the ability to walk.

From Australia to Europe, individuals undergoing clinical trials of stem-cell therapy have been showing a 60 to 80% chance of slowing the disease process, while some may enjoy the benefits of reversing the disease in its entirety. While there is no cure as yet for multiple-sclerosis, stem-cell treatments that focus on repair and regeneration of the central nervous system offer hope to individuals suffering from neural damage around the globe.

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Advancements in Stem Cell Research and Multiple Sclerosis Treatments

Multiple sclerosis is a disease of the immune system that affects the central nervous system, or brain and spinal cord. A form of auto-immune disease, the disease damages the nerves and may affect separate or multiple parts of the body, causing pain and severe limitation to movement, ability, and quality of life.

The disease causes damage and destruction to the protective covering (myelin sheath) that surrounds nerve cells. Damage to the myelin sheath severely slows or interrupts nerve impulses, causing intense pain and inability to control movement. Individuals diagnosed with multiple sclerosis experience episodes of inflammation that cause the body's immune cells to attack the nervous system.

Stem Cell Technologies and Multiple Sclerosis

In recent months, treating a patient who has been diagnosed with multiple sclerosis with their own immune system stem-cells has shown promise in some clinical trials where severe nerve cell damage has not yet occurred.

Clinical trials developed at the Northwestern University Feinberg School Of Medicine in Chicago removed patient's stem-cells in bone marrow, injected chemicals to destroy damaged immune cells and then re-injected the stem-cells into the patient's bodies. Three years later, none of the 23 individuals who engaged in the clinical trials experienced further deterioration, while 17 of them showed some improvement.

In further studies, adult stem-cells that have been taken from a patient's fatty tissues have shown promise in reducing clinical manifestation of the disease process. Clinical trials using mesenchymal stem-cells showed improvement, according to the Journal Of Translational Medicine, describing studies performed at the University of California San Diego. Mesenchymal stem-cells have been shown to reduce or stop immune activation of cells and target specific areas where tissue damage had occurred.

Use of stem-cell technologies to treat multiple sclerosis is designed to literally "reset" immune system function and is focusing on reversing or slowing early diagnosis of multiple sclerosis. Recently, an international symposium (Stem Cell Transplantation in Multiple Sclerosis: Sharing The Experience) was conducted in Moscow, Russia to discuss perspectives in new methods of treating multiple sclerosis through autologous hematopoietic (bone marrow stem-cells that may 'morph' or develop into a variety of stem cell types)stem-cell transplantation combined with high dose immunosuppressive therapies.

The Future of Treatment

In recent months, Brainstorm Cell Therapeutics, Inc., has developed a therapeutic approach for potential treatment of multiple muscular conditions including Parkinson's disease, ALS and multiple-sclerosis. Multiple sclerosis treatments are currently being conducted on mouse models, with results published in the Journal Of Molecular Neuroscience.

Benefits of such treatment offer individuals diagnosed with multiple-sclerosis, especially those diagnosed early, with renewed neural and muscular function, reduced symptoms and enhanced quality of life. News articles abound with stories of various stages of recovery of those who have undergone stem-cell treatment for multiple-sclerosis, some who have even recovered the ability to walk.

From Australia to Europe, individuals undergoing clinical trials of stem-cell therapy have been showing a 60 to 80% chance of slowing the disease process, while some may enjoy the benefits of reversing the disease in its entirety. While there is no cure as yet for multiple-sclerosis, stem-cell treatments that focus on repair and regeneration of the central nervous system offer hope to individuals suffering from neural damage around the globe.

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Advancements in Stem Cell Research and Multiple Sclerosis Treatments

Multiple sclerosis is a disease of the immune system that affects the central nervous system, or brain and spinal cord. A form of auto-immune disease, the disease damages the nerves and may affect separate or multiple parts of the body, causing pain and severe limitation to movement, ability, and quality of life.

The disease causes damage and destruction to the protective covering (myelin sheath) that surrounds nerve cells. Damage to the myelin sheath severely slows or interrupts nerve impulses, causing intense pain and inability to control movement. Individuals diagnosed with multiple sclerosis experience episodes of inflammation that cause the body's immune cells to attack the nervous system.

Stem Cell Technologies and Multiple Sclerosis

In recent months, treating a patient who has been diagnosed with multiple sclerosis with their own immune system stem-cells has shown promise in some clinical trials where severe nerve cell damage has not yet occurred.

Clinical trials developed at the Northwestern University Feinberg School Of Medicine in Chicago removed patient's stem-cells in bone marrow, injected chemicals to destroy damaged immune cells and then re-injected the stem-cells into the patient's bodies. Three years later, none of the 23 individuals who engaged in the clinical trials experienced further deterioration, while 17 of them showed some improvement.

In further studies, adult stem-cells that have been taken from a patient's fatty tissues have shown promise in reducing clinical manifestation of the disease process. Clinical trials using mesenchymal stem-cells showed improvement, according to the Journal Of Translational Medicine, describing studies performed at the University of California San Diego. Mesenchymal stem-cells have been shown to reduce or stop immune activation of cells and target specific areas where tissue damage had occurred.

Use of stem-cell technologies to treat multiple sclerosis is designed to literally "reset" immune system function and is focusing on reversing or slowing early diagnosis of multiple sclerosis. Recently, an international symposium (Stem Cell Transplantation in Multiple Sclerosis: Sharing The Experience) was conducted in Moscow, Russia to discuss perspectives in new methods of treating multiple sclerosis through autologous hematopoietic (bone marrow stem-cells that may 'morph' or develop into a variety of stem cell types)stem-cell transplantation combined with high dose immunosuppressive therapies.

The Future of Treatment

In recent months, Brainstorm Cell Therapeutics, Inc., has developed a therapeutic approach for potential treatment of multiple muscular conditions including Parkinson's disease, ALS and multiple-sclerosis. Multiple sclerosis treatments are currently being conducted on mouse models, with results published in the Journal Of Molecular Neuroscience.

Benefits of such treatment offer individuals diagnosed with multiple-sclerosis, especially those diagnosed early, with renewed neural and muscular function, reduced symptoms and enhanced quality of life. News articles abound with stories of various stages of recovery of those who have undergone stem-cell treatment for multiple-sclerosis, some who have even recovered the ability to walk.

From Australia to Europe, individuals undergoing clinical trials of stem-cell therapy have been showing a 60 to 80% chance of slowing the disease process, while some may enjoy the benefits of reversing the disease in its entirety. While there is no cure as yet for multiple-sclerosis, stem-cell treatments that focus on repair and regeneration of the central nervous system offer hope to individuals suffering from neural damage around the globe.

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Advancements in Stem Cell Research and Multiple Sclerosis Treatments

Multiple sclerosis is a disease of the immune system that affects the central nervous system, or brain and spinal cord. A form of auto-immune disease, the disease damages the nerves and may affect separate or multiple parts of the body, causing pain and severe limitation to movement, ability, and quality of life.

The disease causes damage and destruction to the protective covering (myelin sheath) that surrounds nerve cells. Damage to the myelin sheath severely slows or interrupts nerve impulses, causing intense pain and inability to control movement. Individuals diagnosed with multiple sclerosis experience episodes of inflammation that cause the body's immune cells to attack the nervous system.

Stem Cell Technologies and Multiple Sclerosis

In recent months, treating a patient who has been diagnosed with multiple sclerosis with their own immune system stem-cells has shown promise in some clinical trials where severe nerve cell damage has not yet occurred.

Clinical trials developed at the Northwestern University Feinberg School Of Medicine in Chicago removed patient's stem-cells in bone marrow, injected chemicals to destroy damaged immune cells and then re-injected the stem-cells into the patient's bodies. Three years later, none of the 23 individuals who engaged in the clinical trials experienced further deterioration, while 17 of them showed some improvement.

In further studies, adult stem-cells that have been taken from a patient's fatty tissues have shown promise in reducing clinical manifestation of the disease process. Clinical trials using mesenchymal stem-cells showed improvement, according to the Journal Of Translational Medicine, describing studies performed at the University of California San Diego. Mesenchymal stem-cells have been shown to reduce or stop immune activation of cells and target specific areas where tissue damage had occurred.

Use of stem-cell technologies to treat multiple sclerosis is designed to literally "reset" immune system function and is focusing on reversing or slowing early diagnosis of multiple sclerosis. Recently, an international symposium (Stem Cell Transplantation in Multiple Sclerosis: Sharing The Experience) was conducted in Moscow, Russia to discuss perspectives in new methods of treating multiple sclerosis through autologous hematopoietic (bone marrow stem-cells that may 'morph' or develop into a variety of stem cell types)stem-cell transplantation combined with high dose immunosuppressive therapies.

The Future of Treatment

In recent months, Brainstorm Cell Therapeutics, Inc., has developed a therapeutic approach for potential treatment of multiple muscular conditions including Parkinson's disease, ALS and multiple-sclerosis. Multiple sclerosis treatments are currently being conducted on mouse models, with results published in the Journal Of Molecular Neuroscience.

Benefits of such treatment offer individuals diagnosed with multiple-sclerosis, especially those diagnosed early, with renewed neural and muscular function, reduced symptoms and enhanced quality of life. News articles abound with stories of various stages of recovery of those who have undergone stem-cell treatment for multiple-sclerosis, some who have even recovered the ability to walk.

From Australia to Europe, individuals undergoing clinical trials of stem-cell therapy have been showing a 60 to 80% chance of slowing the disease process, while some may enjoy the benefits of reversing the disease in its entirety. While there is no cure as yet for multiple-sclerosis, stem-cell treatments that focus on repair and regeneration of the central nervous system offer hope to individuals suffering from neural damage around the globe.

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.